Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04661124 · ClinicalTrials.gov registry record
Evaluation of the Heidelberg Engineering SPECTRALIS With Flex Module for In-vivo Imaging in the Supine Position
A clinical trial, sponsored by Heidelberg Engineering.
- Completed
- Registry status
- 88
- Enrollment target
NCT04661124 is a clinical trial that has completed, run by Heidelberg Engineering. The registered enrollment target is 88 participants.
The verdict
NCT04661124 has completed, sponsored by Heidelberg Engineering.
- COMPLETED
- Registry status
- 88 participants
- Enrollment target
Study Summary
This is a prospective clinical study conducted at one clinical site in the United States.
Interventions
- DEVICE SPECTRALIS
- DEVICE SPECTRALIS with Flex Module
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 88 participants |
| Start Date | 2020-12-10 |
| Est. Completion | 2024-04-22 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04661124
The ClinicalTrials.gov registry entry for NCT04661124 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 88 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Heidelberg Engineering, which has 16 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which SPECTRALIS is the first listed.
NCT04661124 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04661124 about?
NCT04661124 is a clinical study titled "Evaluation of the Heidelberg Engineering SPECTRALIS With Flex Module for In-vivo Imaging in the Supine Position". This is a prospective clinical study conducted at one clinical site in the United States.
What is the current status of trial NCT04661124?
This trial is currently completed. The enrollment target is 88 participants. The study started on 2020-12-10. Estimated completion is 2024-04-22.
What interventions are being tested in trial NCT04661124?
The interventions under investigation include: SPECTRALIS (DEVICE), SPECTRALIS with Flex Module (DEVICE).
Who is sponsoring clinical trial NCT04661124?
This trial is sponsored by Heidelberg Engineering, which has 16 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.